comparemela.com
Home
Live Updates
Lynn Mutch Professor - Breaking News
Pages:
Latest Breaking News On - Lynn mutch professor - Page 1 : comparemela.com
Dr Thaker on the RAMP-301 Trial of Avutometinib/Defactinib in Low-Grade Serous Ovarian Cancer
Premal Thaker, MD, MS, discusses the phase 3 RAMP-301 trial of avutometinib plus defactinib in recurrent low-grade serous ovarian cancer.
United kingdom
United states
Premal thaker
Siteman cancer center
Division of gynecologic oncology
Lynn mutch professor
Gynecological oncology
Gynecologic oncology
Oncologists Explore Treatment Options in LGSOC, Look Toward Promising Future
Although there are no FDA-approved treatments specifically indicated for low-grade serous ovarian cancer, therapeutic options for these patients are rapidly expanding, with promising new approaches progressing through clinical development.
United states
Washington university
Davidm omalley
Premalh thaker
Shannonn westin
Onclive news network
Department of obstetrics
Division of gynecologic oncology
Ohio state university college of medicine
University of texas md anderson cancer center
Ohio state university comprehensive cancer center
Department of gynecologic oncology
Division of surgery
Emerging therapies
Low grade serous ovarian cancer
Gynecologic oncology
vimarsana © 2020. All Rights Reserved.